412134
Position
Partner
Company
Jones Day Shanghei
Bio
Tony Chen is a former co-chair of the IP subcommittee of the American Chamber of Commerce in Shanghai and has represented clients in complex cross-border intellectual property matters relating to China since 2004. Multinational companies turn to Tony for protecting their IP rights in China's patent office and courts and for reducing IP risks in China-related technology transactions. Chinese clients enlist Tony for managing patent and trade secret litigation overseas and for licensing technology and creating IP assets on a worldwide basis. Tony has led Jones Day's China IP team and local counsel in representing clients from a variety of industries in patent invalidation and infringement disputes before China's patent reexamination board and IP courts, including Celgene (pharmaceutical), Cree (semiconductor), SharkNinja (consumer electronics), Lowes (household goods), and Milliken (chemicals). He has guided western companies in navigating China's myriad regulations relating to technology import and export, high and new technology enterprises, cybersecurity, foreign patent filing, and human genetic materials. Tony has worked with Jones Day's litigators in the United States and Europe in representing Chinese companies in litigation involving patent infringement, ITC 337 investigation, trade secret misappropriation, and economic espionage prosecution. Tony is a leader in public policy projects promoting strong IP protection in China. He is an advisory member of the U.S.-China IP Cooperation Dialogue organized by the U.S. Chamber of Commerce and Renmin University of China. He was an advisor to Shanghai Pudong New Area and Suzhou BioBay on the development of biotechnology industry.
Agenda
emergingopp_icon

Emerging Opportunities in Global Markets

11:45 AM–5:00 PM Jun 4, 2018

Room 253ABC, Level 2

Katherine AndersenHead of Healthcare Corporate Finance and East/Central Life Science atSilicon Valley Bank Michael ChanSenior VP atHKEX Helen ChenManaging Director, Head of L.E.K. China and Asia Life Sciences atL.E.K. Consulting Tony ChenPartner atJones Day Shanghei Joseph DamondExecutive Vice President, International Affairs atBiotechnology Innovation Organization Yuan-Hua DingExecutive Director and Head of External Science & Innovation atPfizer Monica H.Director, International Affairs atBiotechnology Innovation Organization Edward HuChief Financial Officer and Chief Investment Officers atWuXi AppTec Kewen JinManaging Partner atSerica Partners Alex JungPartner/Managing DIrector atEY-Parthenon Wei LiFounding Partner at6 Dimensions Capital Micah MackisonSenior VP for Corporate Development and Strategy atAssembly Biosciences Wendy PanPartner atSidley Donghui QinDirector of Innovation atFerring Pharmaceuticals Greg ScottFounder and Chairman atChinaBIO Group Victor ShiChairman atBayHelix Alan TurleyDeputy Assistant Secretary for China atU.S. Department of Commerce Jonathan WangSenior VP and Head of Business Development atZai Lab Lijun WuChief Scientific Officer and Senior VP R&D, Fosun Pharma USA atFosun Pharma USA Haishan XiongSenior Vice President for Business Development atFountain Medical Development, Ltd GE YanfengDirector-General of the Research Department of Social Development atDevelopment Research Center of the State Council (DRC) Debra YuManaging Director atChina Renaissance Securities (US) Inc.
Interests
None yet.